Will Rockwell Medical stock go up?

According to Danelfin AI, Rockwell Medical has today an AI Score of 4/10 (Hold rating), because its probability of beating the market in 3 months (50.57%) is -0.25% vs. the average probability (50.82%) of all US-listed stocks.

What is the target price for Rockwell Medical stock?

The Rockwell Medical target price is $24.05 (1Y), according to the average price target offered by analysts.

Is it a good time to buy, sell, or hold Rockwell Medical stock right now?

Rockwell Medical has today a Hold rating (AI Score 4/10), according to Danelfin AI. Its probability of beating the market in 3 months (50.57%) is -0.25% vs. the average probability (50.82%) of all US-listed stocks, based on our AI-powered analysis. You can find more details on whether Rockwell Medical stock is a good buy .

Is Rockwell Medical undervalued right now?

Based on analysts, the average price target upside for Rockwell Medical is +361.54% (1Y). According to Danelfin AI, Rockwell Medical has today an AI Score of 4/10 (Hold Rating).

What was the price range of Rockwell Medical stock over the past 12 months?

The Rockwell Medical stock price range over the past 12 months has been $5.21 - $18.3.

What is going on with Rockwell Medical stock in the last 3 months?

The Rockwell Medical stock performance in the last quarter has been -41.67%.

Does Rockwell Medical offer dividend payments?

No, Rockwell Medical does not currently pay dividends.

What is the current market capitalization of Rockwell Medical?

Rockwell Medical's market cap is $20.48M, as of 2026-07-02 08:00.

When is the next RMTI earnings report date?

RMTI will publish its next earnings report on 2026-05-07.

Rockwell Medical Inc (RMTI) AI Stock Analysis

Advanced Chart

Custom range

Jul 3, 2025

→

Jul 3, 2026

Custom range

Jul 3, 2025

→

Jul 3, 2026

RMTI AI-Powered Stock Analysis

AI Score Explanation

Generating AI Score explanation

We're getting the explanation ready so you can easily understand what's behind the AI Score. This may take a few seconds.

AI Score Explanation

Generating AI Score explanation

We're getting the explanation ready so you can easily understand what's behind the AI Score. This may take a few seconds.

Momentum+0.35%
Direction and strength of recent price movements
Valuation+0.13%
How the stock is priced relative to its fundamentals

Sentiment-0.56%
How analysts and the market view the stock
Profitability-0.08%
Profitability and operating efficiency metrics
Size & Liquidity-0.08%
Company size and trading liquidity
Volatility-0.01%
How much the stock price tends to fluctuate

RMTI probability advantage of beating the market (3M):

-0.25%

AI Score

Hold

Rockwell Medical (RMTI) has an AI Score of 4/10 (Hold) because, according to an overall analysis, it has a probability advantage of -0.25% of beating the market (S&P500) in the next 3 months. This advantage is calculated as the difference between the average probability of any US-listed stock (50.82%) and the probability of RMTI (50.57%) of outperforming the market in the next 3 months, as determined by Danelfin AI’s comprehensive analysis.

Average probability of any US-listed stock of beating the market (3M)50.82%
RMTI probability advantage of beating the market (3M)-0.25%
RMTI probability of beating the market (3M)50.57%

RMTI probability advantage of beating the market (3M): -0.25%

The AI-powered overall analysis of Rockwell Medical (RMTI) is based on the 25 fundamental, technical, and sentiment features that had the greatest impact on stock performance during the last 12 months (alpha signals). These alpha signals explain the probability advantage of RMTI:

Type	Alpha Signal	Current Value	Value Decile Position	Probability Advantage Impact (3M)
Sentiment	Industry (GICS)	Health Care Equipment & Supplies	N/A	-0.27%
Fundamental	Fundamentals Impact (Long Tail)	-	N/A	+0.21%
Technical	Chart Pattern (252d)	figure_36	N/A	-0.18%
Sentiment	Analyst Mean Price Target Upside	-0.41%	N/A	-0.14%
Technical	Chart Pattern (180d)	figure_29	N/A	+0.12%
Sentiment	Fear & Greed Index (CNN)	31	N/A	-0.11%
Technical	Chart Pattern (120d)	figure_161	N/A	+0.11%
Technical	Performance (YTD)	-0.37%		+0.10%
Technical	Technicals Impact (Long Tail)	-	N/A	+0.10%
Technical	Chart Pattern (504d)	figure_16	N/A	-0.10%
Technical	Upgrade to unlock			+0.09%
Fundamental	Upgrade to unlock			-0.08%
Fundamental	Upgrade to unlock			-0.08%
Fundamental	Upgrade to unlock			-0.07%
Sentiment	Upgrade to unlock			+0.06%

Rest of Alpha Signals: +0.01%

RMTI probability advantage of beating the market (3M)Total:-0.25%
RMTI AI Score

Significant changes Vs previous day

RMTI Trading Parameters

These suggested trading parameters for a 3-month horizon help improve risk management and decision-making.

Entry:$5.21
Horizon: 3 months
Stop Loss:$XXXXXPro (XXXXXPro) or AI Score < 4/10
Take Profit:$XXXXXPro (XXXXX
Pro
) or AI Score < 4/10

RMTI Proven Hold Signal & Price Forecast

This is the price chart for RMTI from January 1, 2026 until today. The chart indicates, in yellow, the 69 days when the stock received a Hold rating (hold signals, AI Score 4 to 6).

Forecast: In the section below, the central dotted line represents the most expected path, while the shaded area indicates the anticipated price range. This is based on previous Hold signals with a 90% confidence level.

Full Track Record

Unlock AI-powered forecast

Closing price (USD)
Hold signals

Forecast:

1 Month
3 Months
6 Months
1 Year

RMTI Average Past Performance & Win Rate

Three months after its 1305 Hold signals since July 2026, RMTI had an average performance of xxxxxx and a xxxxxx Win rate (positive performance).

1305 Past RMTI Hold Signals	1 Month Later	3 Months Later	6 Months Later	1 Year Later
Average Performance				-26.23%
Average Alpha				-38.03%
Win Rate (% Positive Perf.)				18.13%
% Positive Alpha				13.93%

RMTI Frequently Asked Questions

Will Rockwell Medical stock go up?
According to Danelfin AI, Rockwell Medical has today an AI Score of 4/10 (Hold rating), because its probability of beating the market in 3 months (50.57%) is -0.25% vs. the average probability (50.82%) of all US-listed stocks.
What is the target price for Rockwell Medical stock?
Is it a good time to buy, sell, or hold Rockwell Medical stock right now?
Is Rockwell Medical undervalued right now?
What was the price range of Rockwell Medical stock over the past 12 months?
What is going on with Rockwell Medical stock in the last 3 months?
Does Rockwell Medical offer dividend payments?
What is the current market capitalization of Rockwell Medical?
When is the next RMTI earnings report date?

Rockwell Medical Inc Company Profile

Rockwell Medical, Inc., along with its subsidiaries, functions as a global healthcare entity. It specializes in the development, production, marketing and distribution of diverse hemodialysis products intended for worldwide dialysis providers. The firm's innovative offerings include Triferic Dialysate and Triferic AVNU, which are uniquely tailored to maintain hemoglobin levels in adults undergoing hemodialysis treatment.

Furthermore, the company exhibits prowess in fabricating, selling, distributing and delivering various potent hemodialysis concentrates such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate and the unique dry acid concentrate mixer. They also house RenalPure and SteriLyte powder bicarbonate concentrate within their product portfolio.

In addition to these mainstay items, Rockwell Medical offers auxiliary products like 5% acetic acid cleaning solution , 5% & 2% citric acid descaler and testing supplies. They also provide filtration salts among other essentials employed by hemodialysis providers worldwide.

Key to their role is designing specialized hemodialysis concentrate products with a primary purpose of removing toxins from patient’s blood-stream while balancing essential electrolytes — ensuring life-sustaining procedures during every session. The clientele served by Rockwell Medical primarily comprises of specialized hemodialysis clinics.

Established in the year 1996, Rockwell Medical has been serving patients for over two decades now. The corporate headquarters is suitably domiciled in Wixom, Michigan.

Sector:
Country:United States
Industry:
Address:30142 Wixom Road, Wixom
Employees:157
Website:rockwellmed.com

Pros

High switching costs for dialysis concentrates

Recurring revenue from chronic kidney disease treatment

Essential medical supply status for dialysis patients

Specialized regulatory approvals for iron replacement therapy

Established distribution network within dialysis clinics

Cons

Customer concentration among large dialysis organizations

Reimbursement risk from government healthcare programs

Competition from larger, diversified medical suppliers

Capital intensity for manufacturing and supply chain

Regulatory compliance burden for pharmaceutical production

Company	AI Score	Compare
FMSFresenius Medical Care AG
DVADaVita Inc
AMWLAmerican Well Corp
BDXBecton Dickinson and Co

Company	AI Score	Compare
FMSFresenius Medical Care AG
DVADaVita Inc
AMWLAmerican Well Corp
BDXBecton Dickinson and Co

RMTI Stock AI Analysis